Please login to the form below

Not currently logged in
Email:
Password:

Ranbaxy wins WHO approval for three HIV drugs

Ranbaxy says that the World Health Organisation has included the company's three HIV treatments in its pre-qualification list

India-based Ranbaxy has revealed that the World Health Organisation (WHO) has included the company's three HIV treatments in its pre-qualification list.

Ranbaxy says it now has 15 Anti Retroviral products (ARVs) in WHO's pre-qualification list, consisting of single and fixed dose combination products. The products are manufactured at the company's accredited sites in India.

The newly included ARVs are presented in compliance kit packs and are designed to enhance patient compliance for medication and are the latest additions to the WHO list.

The compliance packs contain two fixed dose combination tablets of lamivudine or zidovudine or Stavudine, with a single tablet of efavirenz. Of these, lamivudine or stavudine and efavirenz formulations are the first by any company on the WHO list, said Ranbaxy.

Ranbaxy has already filed a range of ARVs for FDA approval and has begun receiving tentative approvals from the US Federal agency under the President's Emergency Plan For AIDS Relief (PEPFAR) programme.

On 10 September, Ranbaxy's shares traded 1.3 per cent up at INR 415.30 on the Mumbai Stock Exchange.

30th September 2008

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Life Healthcare Communications

Life is a creative communications agency offering multi-channel solutions for the healthcare industry. We use a storytelling approach to turn...

Latest intelligence

PM Society Digital Awards – the power of together
Our chief executive, Emma Statham, writes about the value of awards and the power of together....
Seduction_feature_image_thumb.jpg
Seduce anyone in four simple steps
You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...
What Would Jeremy Do? : Assessing the impact of a Corbyn-led Labour government
GK Strategy are delighted to announce the launch our latest briefing paper entitled ‘What Would Jeremy Do? Assessing the impact of a Corbyn-led Labour government’....

Infographics